Iron for Menstruating Women: 18 mg RDA (UL 45 mg/day)

Premenopausal women have a higher iron RDA than men (18 vs 8 mg/day, FDA DRI) due to menstrual blood loss. The adult iron UL remains 45 mg/day. Vitamin C increases non-heme iron absorption while calcium can blunt it. Stacks including multivitamins, prenatals, and standalone iron need careful totals. Heavy menstrual bleeding can deplete ferritin before hemoglobin falls, yet iron still carries overload risk when stacked across multis, prenatals, and standalones without labs. Vitamin C enhances non-heme absorption, helpful when indicated, risky when iron totals are already high. Treat each bottle as a line item with dose, frequency, and ingredient form—not only a brand name. NutriAudit normalizes units, flags duplicate nutrient paths across products, and surfaces totals that approach tolerable upper intake levels from authoritative references. Use the export as a conversation starter with your clinician before surgery, pregnancy, new prescriptions, or whenever symptoms shift alongside product changes. Retail marketing and percent daily value lines do not replace summing the same vitamin or mineral across every source you actually take in a day. Proprietary blends still leave you responsible for recognizable vitamins and minerals underneath; photograph both the marketing panel and the Supplement Facts table when you open a new bottle so later dose reconstruction does not depend on memory alone. Travel jet lag prompts melatonin experiments; altitude and heat change hydration and sodium needs; alcohol-heavy trips stress thiamine context. “Immunity weeks” before travel often stack vitamin C, zinc lozenges, elderberry, and multis simultaneously. Training camps for athletes layer creatine, caffeine, beta-alanine, electrolytes, and protein until stimulant load and GI distress dominate recovery. None of these are forbidden; they require honest totals and sleep hygiene basics that supplements cannot replace. If you compete under anti-doping rules, batch-tested products matter more than trendy pre-workout branding. FDA Dietary Reference Intakes publish Recommended Dietary Allowances and Tolerable Upper Intake Levels so consumers and clinicians can compare habitual intake to evidence-based safety envelopes. Those numbers assume you add every relevant source in a day: tablets, capsules, powders, functional beverages, and sometimes fortified foods that repeat the same nutrient under unfamiliar names. When two products both say “immune support” but one lists ascorbic acid and another lists mineral ascorbates, your audit still has to treat them as the same vitamin C ledger entry. The same aggregation rule applies to retinol esters, multiple forms of magnesium salts, and duplicate B vitamins across energy products. NutriAudit’s overlap engine is designed to mirror that regulatory mindset: totals first, brand stories second. If your summed intake approaches or exceeds a UL, the next step is clinician review, not another retail product to “balance” the stack without labs. Polypharmacy amplifies supplement risk because prescription drugs change absorption, metabolism, excretion, and baseline organ reserve. Acid-reducing therapy alters B12, iron, and magnesium handling; warfarin interacts with vitamin K consistency; metformin lowers B12 over years; and many narrow-therapeutic-index drugs conflict with strong CYP450 inducers such as St John’s wort. Even when a supplement is “OTC,” perioperative management may require pausing products that affect bleeding, glucose, blood pressure, or sedation. Older adults metabolize and excrete differently; children require weight-based thinking; pregnancy changes teratogenic and hematologic priorities. Your audit should therefore include prescription and OTC medications alongside supplements, not as an afterthought. Fat-soluble vitamins accumulate in tissue stores, so chronic modest excess can matter even when each individual dose “looks fine” relative to a marketing claim. Water-soluble vitamins are cleared faster, yet several still have real ULs, vitamin C, vitamin B6, and niacin are common examples, or predictable dose-dependent side effects at chronic high intake. Minerals such as iron, zinc, copper, selenium, and iodine participate in narrow therapeutic windows where deficiency and toxicity are both clinically relevant. Electrolytes like potassium become dangerous quickly when kidney function declines or when RAAS-inhibiting medications are present. Herbal and adaptogen categories add pharmacologic variability even when labels say “natural.” Thinking in categories, fat-soluble, UL minerals, sedating herbals, enzyme-inducing herbals, helps prioritize what to audit first. Kidney disease shifts the safety curve for magnesium, potassium, vitamin D metabolites, and some protein-adjacent supplement categories. Liver disease changes retinoid storage, clotting factor production, and detoxification capacity for concentrated herbal extracts. Malabsorption syndromes, bariatric anatomy, celiac disease, and inflammatory bowel flares change which forms and doses are appropriate even when a generic blog recommends a “standard” amount. Athletes may have higher turnover for some nutrients yet still face iron misadventure if they stack multiple iron paths without ferritin monitoring. None of these contexts are solved by buying a more expensive brand; they require individualized medical planning with periodic labs when indicated. NutriAudit encourages you to export a single stack summary for clinicians whenever totals approach reference limits or when new symptoms coincide with product changes. Revisit the audit after hospital discharge, a course of antibiotics, intentional weight loss, or any sustained diet pattern shift that changes what you eat every day.